Their results show that the combination therapy of IL-15 after NIR-PIT inhibited tumour growth, prolonged survival, and increased tumour infiltrating CD8+ T cells more efficiently than NIR-PIT alone. The gene discussed is CD8A; the disease is neoplasm.